These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 10374)
1. Identification of new in vivo side-chain acid metabolites of delta1-tetrahydrocannabinol. Martin BR; Harvey DJ; Paton WD J Pharm Pharmacol; 1976 Oct; 28(10):773-4. PubMed ID: 10374 [No Abstract] [Full Text] [Related]
2. Brain microsomal oxidation of delta 8- and delta 9-tetrahydrocannabinol. Watanabe K; Tanaka T; Yamamoto I; Yoshimura H Biochem Biophys Res Commun; 1988 Nov; 157(1):75-80. PubMed ID: 2848522 [TBL] [Abstract][Full Text] [Related]
3. Chemical synthesis and biological occurrence of carboxylic acid metabolites of delta1(6)-tetrahydrocannabinol. Agurell S; Edward C; Halldin M; Leander K; Levy S; Lindgren JE; Mechoulam R; Noreqvist M; Ohlsson A Drug Metab Dispos; 1979; 7(3):155-61. PubMed ID: 38086 [TBL] [Abstract][Full Text] [Related]
4. The mass spectra of the trimethylsilyl derivatives of the hydroxy and acid metabolites of delta 1- and delta 6-tetrahydrocannabinol. Harvey DJ Biomed Mass Spectrom; 1981 Dec; 8(12):579-88. PubMed ID: 6275928 [TBL] [Abstract][Full Text] [Related]
5. Identification of di- and tri-substituted hydroxy and ketone metabolites of delta1-tetrahydrocannabinol in mouse liver. Harvey DJ; Martin BR; Paton WD J Pharm Pharmacol; 1977 Aug; 29(8):482-6. PubMed ID: 19597 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the butyl homologues of delta1-tetrahydrocannabinol, cannabinol and cannabidiol in samples of cannabis by combined gas chromatography and mass spectrometry. Harvey DJ J Pharm Pharmacol; 1976 Apr; 28(4):280-5. PubMed ID: 6715 [TBL] [Abstract][Full Text] [Related]
7. Identification of metabolites of delta1- and delta1(6)-tetrahydrocannabinol containing a reduced double bond. Harvey DJ; Martin BR; Paton WD J Pharm Pharmacol; 1977 Aug; 29(8):495-7. PubMed ID: 19600 [No Abstract] [Full Text] [Related]
8. More acidic metabolites of delta1-tetrahydrocannabinol isolated from rabbit urine. Nordqvist M; Agurell S; Rydberg M; Falk L; Ryman T J Pharm Pharmacol; 1979 Apr; 31(4):238-43. PubMed ID: 36463 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of delta1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism. Widman M; Nordqvist M; Dollery CT; Briant RH J Pharm Pharmacol; 1975 Nov; 27(11):842-8. PubMed ID: 1493 [TBL] [Abstract][Full Text] [Related]
10. Acidic metabolites of delta1-tetrahydrocannabinol isolated from rabbit urine. Nordqvist M; Lindgren JE; Agurell S J Pharm Pharmacol; 1979 Apr; 31(4):231-7. PubMed ID: 36462 [TBL] [Abstract][Full Text] [Related]
11. Brain levels and relative potency of the 1,2-dimethylheptyl analogue of delta1-tetrahydrocannabinol in mice. Lawrence DK; Pertwee RG; Gill EW; Piper JM Biochem Pharmacol; 1974 Nov; 23(21):3017-27. PubMed ID: 4429599 [No Abstract] [Full Text] [Related]
12. Identification of a C-glucuronide of delta6- tetrahydrocannabinol as a mouse liver conjugate in vivo. Levy S; Yagen B; Mechoulam R Science; 1978 Jun; 200(4348):1390-2. PubMed ID: 663618 [TBL] [Abstract][Full Text] [Related]
13. Confirmation of cannabis use. II. Determination of tetrahydrocannabinol metabolites in urine and plasma by HPLC with ECD. Nakahara Y; Sekine H; Cook CE J Anal Toxicol; 1989; 13(1):22-4. PubMed ID: 2540383 [TBL] [Abstract][Full Text] [Related]
14. (-)-8beta-hydroxymethyl-delta1-tetrahydrocannabinol: a novel physiologically active analog of delta1-tetrahydrocannabinol. Razdan RK; Howes JF; Uliss DB; Dalzell HC; Handrick GR; Dewey WL Experientia; 1976 Apr; 32(4):416-7. PubMed ID: 1269636 [No Abstract] [Full Text] [Related]
15. In vivo metabolites of delta1(6)-tetrahydrocannabinol produced by the mouse via the epoxide-diol pathway. Harvey DJ; Paton WD J Pharm Pharmacol; 1977 Aug; 29(8):498-500. PubMed ID: 19601 [No Abstract] [Full Text] [Related]
16. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice. Gill EW; Jones G; Lawrence DK Biochem Pharmacol; 1973 Jan; 22(2):175-84. PubMed ID: 4763251 [No Abstract] [Full Text] [Related]
17. Metabolism of n-hexyl-homologues of delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in the mouse. Brown NK; Harvey DJ Eur J Drug Metab Pharmacokinet; 1988; 13(3):165-76. PubMed ID: 2853671 [TBL] [Abstract][Full Text] [Related]
18. Microsomal oxygenase catalyzed oxidation of 11-hydroxy-delta 8-tetrahydrocannabinol to 11-oxo-delta 8-tetrahydrocannabinol. Watanabe K; Yamamoto I; Oguri K; Yoshimura H Biochem Biophys Res Commun; 1979 May; 88(1):178-82. PubMed ID: 36896 [No Abstract] [Full Text] [Related]
19. Antibody-mediated extraction of the main tetrahydrocannabinol metabolite, 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid, from human urine and its identification by gas chromatography-mass spectrometry in the sub-nanogram range. Lemm U; Tenczer J; Baudisch H; Krause W J Chromatogr; 1985 Aug; 342(2):393-8. PubMed ID: 2997252 [No Abstract] [Full Text] [Related]
20. Proof of active cannabis use comparing 11-hydroxy-∆9-tetrahydrocannabinol with 11-nor-9-carboxy-tetrahydrocannabinol concentrations. Franz T; Skopp G; Schwarz G; Musshoff F Drug Test Anal; 2018 Oct; 10(10):1573-1578. PubMed ID: 29845743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]